References
1. Bokhman Ya.V. Guide oncogynecology. Saint Petersburg: Foliant, 2002: 542 p. (in Russian)
2. Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol. 2005; 123 (suppl): 13-57.
3. Gotlieb W.H., Chetrit A., Menczer J., et al. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gynecol Oncol. 2005; 97 (3): 780-3.
4. Lodhi S., Najam S., Pervez S. DNA ploidy analysis of borderline epithelial ovarian tumours. J Pak Med Assoc. 2000; 50 (10): 349-51.
5. Lu K.H., Cramer D.W., Muto M.G., et al. A population-based study of BRCA1 and BRCA2mutations in Jewish women with epithelial ovarian cancer. Obstet Gynecol. 1999; 93 (1): 34-7.
6. Riman T., Dickman P.W., Nilsson S., et al. Risk factors for epithelial borderline ovarian tumors: result of a Swedish case - control study. Gynecol Oncol. 2001; 83 (3): 575-85.
7. Scully R.E., Young R.H., Clement P.B. Tumor like lesions. In: Tumors of the Ovary and Maldeveloped Gonads, Fallopian Tube and Broad Ligament. Washington: Armed Forces Institute of Pathology, 1998: 443-4.
8. Shim S.H., Kim S.N., Jung P.S., et al. Impact of surgical staging on prognosis in patients with borderline ovarian tumours: a meta-analysis. Eur J Cancer. 2016; 54: 84-95.
9. Silva E.G., Kurman R.J., Russell P., Scully R.E. Symposium: ovarian tumors of borderline malignancy. Int J Gynecol Pathol. 1996; 15 (4): 281302.
10. Gubina O.V. Features of clinical course and treatment of borderline ovarian tumors. Diss. Мoscow, 1995. 78 р. (in Russian)
11. Ayhan A., Akarin R., Develioglu O., et al. Borderline epithelial ovarian tumors. Aust N Z J Obstet. Gynecol. 1991; 31 (2): 174-6.
12. Goldman T.L., Chalas E., Chumas J., et al. Management of borderline tumors of the ovary. South Med J. 1993; 86 (4): 423-5.
13. Jimenez A.M., Miralles Pi R.M., Sanchez A.E., et al. Ovarian tumors of low malignant potential (borderline). A retrospective study of 31 cases. Eur J Gynaecol Oncol. 1994; 15 (4): 300-4.
14. Welander C.E. What do CA-125 and other antigens tell us about ovarian cancer biology? Acta Obstet Gynecol. Scand. 1992; 155 (suppl): 85-93.
15. Gus A.I. Ultrasonic diagnosis of precancerous conditions and early forms of serous ovarian cancer. Materials of the Russian Symposium with international participation “Screening and new approaches to the treatment of initial gynecological cancer” (Novgorod, June 23-24, 1994). St. Petersburg., 1994: 33-34. (in Russian)
16. de Souza N.M., O'Neill R., McIndoe G.A., et al. Borderline tumors of the ovary: CT and MRI features and tumor markers in differentiation from stage I disease. AJR Am J Roentgenol. 2005; 184 (3): 999-1003.
17. Davydova I.Yu., Kuznetsov V.V., Karseladze A.I., Meshcheryakova L.A. Borderline ovarian tumors: the issues of chemotherapy and prognosis. Opukholi zhenskoy reproduktivnoy sistemy [Tumors of Female Reproductive System]. 2015; 11 (3): 72-5. (in Russian)
18. Novikova E.G., Shevchuk A.S., Zavalishina L.E. Some aspects of borderline ovarian tumors organ-preserving treatment. Rossiyskiy onko-logicheskiy zhurnal [Russian Oncology Journal]. 2010 (4): 15-20. (in Russian)
19. Heintz A.P., Odicino F., Maisonneuve P., et al. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol. Obstet. 2006; 95 (suppl 1): 161-92.
20. Vasconcelos I. Management of borderline ovarian tumors - state of the art. Uterus Ovary. 2015; 2: 1-6.
21. Vasconcelos I., de Sousa Mendes M. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk. Eur J Cancer. 2015; 51 (5): 620-31.
22. Glazunov M.F. Ovarian tumors (morphology, histogenesis, pathogenesis issues). Leningrad: Medgiz, 1961: 336 p. (in Russian)
23. Zheleznov B.I. Issues of differential histological diagnosis of benign, proliferating (borderline) tumors and early forms of ovarian malignant tumors. Moscow, 1984: 50-3. (in Russian)
24. Karseladze A.I. To the morphology of mucinous borderline ovarian tumors Arkhiv patologii [Archive of Pathology]. 1989; 51 (5): 40-6. (in Russian)
25. Hogg R., Scurry J., Kim S.N., et al. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma. Gynecol Oncol. 2007; 106 (1): 44-51.
26. Leitao M.M. Micropapillary pattern in newly diagnosed borderline tumors of the ovary: what's in a name? Oncologist. 2011; 16 (2): 133-5.
27. Longacre T.A., Kempson R.L., Hendrickson M.R. Well-differentiated serous neoplasms of the ovary. Pathology (Phila). 1993; 1 (2): 255-306.
28. Morice P., Camatte S., Wicart-Poque F., et al. Results of conservative management of epithelial malignant and borderline ovarian tumours. Hum Reprod Update. 2003; 9 (2): 185-92.
29. Morice P., Uzan C., Fauvet R., et al. Borderline ovarian tumour: pathological diagnostic dilemma and risk factor for invasive or lethal recurrence. Lancet Oncol. 2012; 13 (3): 103-15.
30. Silva E.G., Gershenson D.M., Malpica A., Deavers M. The recurrence and the overall survival rates of ovarian serous border line neoplasms with noninvasive implants is time dependent. Am J Surg Pathol. 2006; 30 (11): 1367-71.
31. McKenney J.K., Balzer B.L., Longacre T.A. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion. Am J Surg Pathol. 2006; 30 (10): 1209-21.
32. Mooney J., Silva E., Tornos C., Gershenson D., et al. Unusual features of serous neoplasms of low malignant potential during pregnancy. Gynecol Oncol. 1997; 65 (1): 30-5.
33. Katzenstein A.L., Mazur M.T., Morgan T.E., Kao M.S. Proliferative serous tumors of the ovary. Histologic features and prognosis. Am J Surg Pathol. 1978; 2 (4): 339-55.
34. Kurman R.J., Carcanqiu M.L., Herrington C.S., Young R.H. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon : IARS, 2014: 307 p.
35. Fadare O. Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors). Int J Gynecol Cancer. 2009; 19 (1): 103-8.
36. Kempson R.L., Hendrickson M.R. Ovarian serous borderline tumors: the citadel defended. Hum Pathol. 2000; 31 (5): 525-6.
37. Shih le M., Kurman R.J. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004; 164 (5): 1511-8.
38. Shih le M., Kurman R.J. Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin Cancer Res. 2005; 11 (20): 7273-9.
39. Burks R.T., Sherman M.E., Kurman R.J. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol. 1996; 20 (11): 1319-30.
40. Seidman J.D., Kurman R.J. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol. 2000; 31 (5): 539-57.
41. Du Bois A., Ewald-Riegler N., du Bois O., Harter P. Borderline tumors of the ovary - a systematic review. Geburtsh Frauenheilk. 2009; 69: 807-33.
42. Trope C., Davidson B., Paulsen T., et al. Diagnosis and treatment of borderline ovarian neoplasms "the state of the art". Eur J Gynaecol. Oncol. 2009; 30 (5): 471-82.
43. Fauvet R., Poncelet C., Boccara J., et al. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study. Fertil Steril. 2005; 83 (2): 284-90.
44. Tinelli F., Tinelli R., La Grotta F., et al. Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors. Acta Obstet Gynecol. Scand. 2007; 86 (1): 81-7.
45. Hauptmann S., Friedrich K., Redline R., Avril S. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria. Virchows Arch. 2017; 470 (2): 125-42.
46. Kleppe М., Bruls J., van Gorp T., Massuger L., et al. Mucinous borderline tumours of the ovary and the appendix: a retrospective study and overview of the literature. Gynecol Oncol. 2014; 133 (2): 155-8.